The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Leqembi (lecanemab)
Australian Public Assessment Report
Device/Product Name
LEQEMBI
Active ingredients
Lecanemab
AusPAR Date
Published
Sponsor
Submission Number
PM-2023-02164-1-1
Submission Type
New biological medicine
Decision
Not approved